Search results
Results from the WOW.Com Content Network
Japanese encephalitis vaccine is a vaccine that protects against Japanese encephalitis. [2] The vaccines are more than 90% effective. [2] The duration of protection with the vaccine is not clear but its effectiveness appears to decrease over time. [2] Doses are given either by injection into a muscle or just under the skin. [2]
1982: Two doses of MMR vaccination at 14–18 months and 6 years of age were introduced in the national childhood vaccination programme. 2009: Rotavirus vaccine introduced at 2, 3 and 5 months to all children (September 2009) 2010: PCV introduced at 3, 5 and 12 months of age to all children (September 2010). 2013: HPV vaccination of girls ...
A hexavalent vaccine, or 6-in-1 vaccine, is a combination vaccine with six individual vaccines conjugated into one, intended to protect people from multiple diseases. [1] [9] The term usually refers to the children's vaccine that protects against diphtheria, tetanus, pertussis, poliomyelitis, haemophilus B, and hepatitis B, [1] [9] which is used in more than 90 countries around the world ...
There are very few true contraindication and precaution conditions. Only two of these conditions are generally considered to be permanent: severe (anaphylactic) allergic reaction to a vaccine component or following a prior dose of a vaccine, and encephalopathy not due to another identifiable cause occurring within 7 days of pertussis vaccination.
A pentavalent vaccine combines five vaccines into one dose. Pentavalent vaccines include: DTwP-HepB-Hib vaccine, used by UNICEF in low/middle income countries;
A booster dose is an extra administration of a vaccine after an earlier dose. After initial immunization , a booster provides a re-exposure to the immunizing antigen . It is intended to increase immunity against that antigen back to protective levels after memory against that antigen has declined through time.
Fractional dose vaccination [1] [2] is a strategy to reduce the dose of a vaccine to achieve a vaccination policy goal that is more difficult to achieve with conventional vaccination approaches, including deploying a vaccine faster in a pandemic, [3] reaching more individuals in the setting of limited healthcare budgets, or minimizing side effects due to the vaccine.
The two tablets of adenovirus vaccine, one with adenovirus type 4 and the other with type 7, each contain 32,000 tissue-culture infective doses (10 4.5 TCID 50). [3] The current live polio vaccine contains two serotypes of poliovirus: over 1 million tissue-culture infective doses (10 6 TCID 50) of type 1 and over 630,000 (10 5.8 TCID 50) of ...